StockData
Pulmonx Corp logo

Pulmonx Corp (LUNG) stock

LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3042% below fair value
$2.73−0.06 (-2.32%)

Close on Nov 17, 2026Market cap $117.46MP/E –Yield –

Pulmonx price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Pulmonx's price to sales ratio was 1.5× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.6× to 26.5×, with a median of 4.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.5×+0.5
2025Dec 31, 20251.0×−2.4
2024Dec 31, 20243.4×−4.2
2023Dec 29, 20237.5×+1.5
2022Dec 30, 20226.1×−20.4
2021Dec 31, 202126.5×+18.6
2020Dec 31, 20207.9×–

More Pulmonx figures

See a number that looks wrong?